Despite the rapidly evolving treatment landscape in advanced non-small-cell lung cancer
(NSCLC), developments in neoadjuvant and adjuvant treatments have been nascent by …

Lung, breast, and esophageal cancer represent three common malignancies with high
incidence and mortality worldwide. The management of these tumors critically relies on …

Purpose The purpose was to explore the effects of total-body PET/CT with half-dose 18 F-
FDG activity on image quality, compared with those of conventional PET/CT with clinical …

Introduction The RTOG 0617 trial presented a worse survival for patients with lung cancer
treated in the high-dose (74 Gy) arm. In multivariable models, radiation level and whole …

Background Glioblastoma (GBM) systematically recurs after a standard 60 Gy radio-
chemotherapy regimen. Since magnetic resonance spectroscopic imaging (MRSI) has been …

Abstract Purpose 2-[18 F] FDG PET/CT is of utmost importance for radiation treatment (RT)
planning and response monitoring in lung cancer patients, in both non-small and small cell …

Background [18F] FDG imaging on total-body PET/CT (TB PET/CT) scanners, with improved
sensitivity, offers new potentials for cancer diagnosis, staging, and radiation treatment …

Since the development of fibroblast activation protein–targeted radiopharmaceuticals, 68Ga-
fibroblast activation protein inhibitor (FAPI) PET/CT has been found to be suitable for …

Background and purpose We aimed to assess if radiation dose escalation to either the
whole primary tumour, or to an 18 F-FDG-PET defined subvolume within the primary tumour …

Medical physics has made considerable contributions to recent advances in radiation
oncology. Medical physicists are key players in the clinical and scientific radiation oncology …